On October 9, the Board of Pharmacy updated two items below:
The Opioid Prescription Drug Fact Sheet that must be distributed when dispensing a Schedule II or III prescription has been updated to reflect statutory changes. Please also note the change to state law that requires an opioid antagonist (e.g., naloxone) to be offered whenever a Schedule II opioid is dispensed.
Policy 2023-09: Action Level Environmental Monitoring Results
The requirement for growth identification in all ISO 7 areas is now only required for ISO 7 buffer rooms. This is in addition to the current identification mandates for ISO 5 areas and any action level growth in any ISO classified areas. Compounding during remediation now also differentiates between ISO 7 buffer rooms and other ISO 7 areas.
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.